Radiopharmaceutical Market Report

1. Global Radiopharmaceutical Executive Summary

• 1.1 Introduction

• 1.2 Market Panorama, 2022

2 Coronavirus Impact

• 2.1 Radiopharmaceutical Outlook to 2028- Original Forecasts

• 2.2 Radiopharmaceutical Outlook to 2028- COVID-19 Affected Forecasts

• 2.3 Impact on Industry

3 Strategic Analytics to Boost Productivity and Profitability

• 3.1 Potential Market Drivers and Opportunities

• 3.2 New Challenges and Strategies

• 3.3 Short Term and Long Term Radiopharmaceutical Market Trends

4 Key Inferences

5 Market Overview

• 5.1 Current Market Scenario

• 5.2 Porter's Five Forces Analysis

• 5.2.1 Bargaining Power of Suppliers

• 5.2.2 Bargaining Power of Consumers

• 5.2.3 Threat of New Entrants

• 5.2.4 Threat of Substitute Product and Services

• 5.2.5 Competitive Rivalry within the Industry

6 Global Radiopharmaceutical Market- Recent Developments

• 6.1 Radiopharmaceutical Market News and Developments

• 6.2 Radiopharmaceutical Market Deals Landscape

7 Radiopharmaceutical Raw Materials and Cost Structure Analysis

• 7.1 Radiopharmaceutical Key Raw Materials

• 7.2 Radiopharmaceutical Price Trend of Key Raw Materials

• 7.3 Radiopharmaceutical Key Suppliers of Raw Materials

• 7.4 Radiopharmaceutical Market Concentration Rate of Raw Materials

• 7.5 Radiopharmaceutical Cost Structure Analysis

• 7.5.1 Radiopharmaceutical Raw Materials Analysis

• 7.5.2 Radiopharmaceutical Labor Cost Analysis

• 7.5.3 Radiopharmaceutical Manufacturing Expenses Analysis

8 Global Radiopharmaceutical Import and Export Analysis (Top 10 Countries)

• 8.1 Global Radiopharmaceutical Import by Region (Top 10 Countries) (2017-2028)

• 8.2 Global Radiopharmaceutical Export by Region (Top 10 Countries) (2017-2028)

9 Global Radiopharmaceutical Market Outlook by Types and Applications to 2022

• 9.1 Global Radiopharmaceutical Consumption and Growth Rate by Type (2017-2022)

• 9.1.1 Global Actinium-225 Consumption and Growth Rate (2017-2022)

• 9.1.2 Global Lutetium-177 Consumption and Growth Rate (2017-2022)

• 9.1.3 Global Radium-223 Consumption and Growth Rate (2017-2022)

• 9.1.4 Global Holmium-166 Consumption and Growth Rate (2017-2022)

• 9.1.5 Global Other Consumption and Growth Rate (2017-2022)

• 9.2 Global Radiopharmaceutical Consumption and Growth Rate by Application (2017-2022)

• 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

• 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

10 Region and Country-wise Radiopharmaceutical Market Analysis and Outlook till 2022

• 10.1 Global Radiopharmaceutical Consumption (2017-2022)

• 10.2 North America Consumption Analysis

• 10.2.1 United States Radiopharmaceutical Consumption (2017-2022)

• 10.2.2 Canada Radiopharmaceutical Consumption (2017-2022)

• 10.2.3 Mexico Radiopharmaceutical Consumption (2017-2022)

• 10.3 Europe Consumption Analysis

• 10.3.1 Germany Radiopharmaceutical Consumption (2017-2022)

• 10.3.2 UK Radiopharmaceutical Consumption (2017-2022)

• 10.3.3 Spain Radiopharmaceutical Consumption (2017-2022)

• 10.3.4 Belgium Radiopharmaceutical Consumption (2017-2022)

• 10.3.5 France Radiopharmaceutical Consumption (2017-2022)

• 10.3.6 Italy Radiopharmaceutical Consumption (2017-2022)

• 10.3.7 Denmark Radiopharmaceutical Consumption (2017-2022)

• 10.3.8 Finland Radiopharmaceutical Consumption (2017-2022)

• 10.3.9 Norway Radiopharmaceutical Consumption (2017-2022)

• 10.3.10 Sweden Radiopharmaceutical Consumption (2017-2022)

• 10.3.11 Poland Radiopharmaceutical Consumption (2017-2022)

• 10.3.12 Russia Radiopharmaceutical Consumption (2017-2022)

• 10.3.13 Turkey Radiopharmaceutical Consumption (2017-2022)

• 10.4 APAC Consumption Analysis

• 10.4.1 China Radiopharmaceutical Consumption (2017-2022)

• 10.4.2 Japan Radiopharmaceutical Consumption (2017-2022)

• 10.4.3 India Radiopharmaceutical Consumption (2017-2022)

• 10.4.4 South Korea Radiopharmaceutical Consumption (2017-2022)

• 10.4.5 Pakistan Radiopharmaceutical Consumption (2017-2022)

• 10.4.6 Bangladesh Radiopharmaceutical Consumption (2017-2022)

• 10.4.7 Indonesia Radiopharmaceutical Consumption (2017-2022)

• 10.4.8 Thailand Radiopharmaceutical Consumption (2017-2022)

• 10.4.9 Singapore Radiopharmaceutical Consumption (2017-2022)

• 10.4.10 Malaysia Radiopharmaceutical Consumption (2017-2022)

• 10.4.11 Philippines Radiopharmaceutical Consumption (2017-2022)

• 10.4.12 Vietnam Radiopharmaceutical Consumption (2017-2022)

• 10.5 South America Consumption Analysis

• 10.5.1 Brazil Radiopharmaceutical Consumption (2017-2022)

• 10.5.2 Colombia Radiopharmaceutical Consumption (2017-2022)

• 10.5.3 Chile Radiopharmaceutical Consumption (2017-2022)

• 10.5.4 Argentina Radiopharmaceutical Consumption (2017-2022)

• 10.5.5 Venezuela Radiopharmaceutical Consumption (2017-2022)

• 10.5.6 Peru Radiopharmaceutical Consumption (2017-2022)

• 10.5.7 Puerto Rico Radiopharmaceutical Consumption (2017-2022)

• 10.5.8 Ecuador Radiopharmaceutical Consumption (2017-2022)

• 10.6 GCC Consumption Analysis

• 10.6.1 Bahrain Radiopharmaceutical Consumption (2017-2022)

• 10.6.2 Kuwait Radiopharmaceutical Consumption (2017-2022)

• 10.6.3 Oman Radiopharmaceutical Consumption (2017-2022)

• 10.6.4 Qatar Radiopharmaceutical Consumption (2017-2022)

• 10.6.5 Saudi Arabia Radiopharmaceutical Consumption (2017-2022)

• 10.6.6 United Arab Emirates Radiopharmaceutical Consumption (2017-2022)

• 10.7 Africa Consumption Analysis

• 10.7.1 Nigeria Radiopharmaceutical Consumption (2017-2022)

• 10.7.2 South Africa Radiopharmaceutical Consumption (2017-2022)

• 10.7.3 Egypt Radiopharmaceutical Consumption (2017-2022)

• 10.7.4 Algeria Radiopharmaceutical Consumption (2017-2022)

• 10.8 Oceania Consumption Analysis

• 10.8.1 Australia Radiopharmaceutical Consumption (2017-2022)

• 10.8.2 New Zealand Radiopharmaceutical Consumption (2017-2022)

11 Global Radiopharmaceutical Competitive Analysis

• 11.1 Triad Isotopes

• 11.1.1 Triad Isotopes Company Details

• 11.1.2 Triad Isotopes Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• 11.1.3 Triad Isotopes Radiopharmaceutical Main Business and Markets Served

• 11.1.4 Triad Isotopes Radiopharmaceutical Product Portfolio

• 11.1.5 Recent Research and Development Strategies

• 11.2 Navidea

• 11.2.1 Navidea Company Details

• 11.2.2 Navidea Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• 11.2.3 Navidea Radiopharmaceutical Main Business and Markets Served

• 11.2.4 Navidea Radiopharmaceutical Product Portfolio

• 11.2.5 Recent Research and Development Strategies

• 11.3 Eli Lilly

• 11.3.1 Eli Lilly Company Details

• 11.3.2 Eli Lilly Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• 11.3.3 Eli Lilly Radiopharmaceutical Main Business and Markets Served

• 11.3.4 Eli Lilly Radiopharmaceutical Product Portfolio

• 11.3.5 Recent Research and Development Strategies

• 11.4 Bracco Imaging

• 11.4.1 Bracco Imaging Company Details

• 11.4.2 Bracco Imaging Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• 11.4.3 Bracco Imaging Radiopharmaceutical Main Business and Markets Served

• 11.4.4 Bracco Imaging Radiopharmaceutical Product Portfolio

• 11.4.5 Recent Research and Development Strategies

• 11.5 IBA Group

• 11.5.1 IBA Group Company Details

• 11.5.2 IBA Group Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• 11.5.3 IBA Group Radiopharmaceutical Main Business and Markets Served

• 11.5.4 IBA Group Radiopharmaceutical Product Portfolio

• 11.5.5 Recent Research and Development Strategies

• 11.6 Jubilant Pharma

• 11.6.1 Jubilant Pharma Company Details

• 11.6.2 Jubilant Pharma Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• 11.6.3 Jubilant Pharma Radiopharmaceutical Main Business and Markets Served

• 11.6.4 Jubilant Pharma Radiopharmaceutical Product Portfolio

• 11.6.5 Recent Research and Development Strategies

• 11.7 Nordion

• 11.7.1 Nordion Company Details

• 11.7.2 Nordion Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• 11.7.3 Nordion Radiopharmaceutical Main Business and Markets Served

• 11.7.4 Nordion Radiopharmaceutical Product Portfolio

• 11.7.5 Recent Research and Development Strategies

• 11.8 Mallinckrodt

• 11.8.1 Mallinckrodt Company Details

• 11.8.2 Mallinckrodt Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• 11.8.3 Mallinckrodt Radiopharmaceutical Main Business and Markets Served

• 11.8.4 Mallinckrodt Radiopharmaceutical Product Portfolio

• 11.8.5 Recent Research and Development Strategies

• 11.9 Advanced Accelerator Applications

• 11.9.1 Advanced Accelerator Applications Company Details

• 11.9.2 Advanced Accelerator Applications Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• 11.9.3 Advanced Accelerator Applications Radiopharmaceutical Main Business and Markets Served

• 11.9.4 Advanced Accelerator Applications Radiopharmaceutical Product Portfolio

• 11.9.5 Recent Research and Development Strategies

• 11.10 SIEMENS

• 11.10.1 SIEMENS Company Details

• 11.10.2 SIEMENS Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• 11.10.3 SIEMENS Radiopharmaceutical Main Business and Markets Served

• 11.10.4 SIEMENS Radiopharmaceutical Product Portfolio

• 11.10.5 Recent Research and Development Strategies

• 11.11 GE Healthcare

• 11.11.1 GE Healthcare Company Details

• 11.11.2 GE Healthcare Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• 11.11.3 GE Healthcare Radiopharmaceutical Main Business and Markets Served

• 11.11.4 GE Healthcare Radiopharmaceutical Product Portfolio

• 11.11.5 Recent Research and Development Strategies

• 11.12 China Isotope & Radiation

• 11.12.1 China Isotope & Radiation Company Details

• 11.12.2 China Isotope & Radiation Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• 11.12.3 China Isotope & Radiation Radiopharmaceutical Main Business and Markets Served

• 11.12.4 China Isotope & Radiation Radiopharmaceutical Product Portfolio

• 11.12.5 Recent Research and Development Strategies

• 11.13 Dongcheng

• 11.13.1 Dongcheng Company Details

• 11.13.2 Dongcheng Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• 11.13.3 Dongcheng Radiopharmaceutical Main Business and Markets Served

• 11.13.4 Dongcheng Radiopharmaceutical Product Portfolio

• 11.13.5 Recent Research and Development Strategies

• 11.14 Bayer

• 11.14.1 Bayer Company Details

• 11.14.2 Bayer Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• 11.14.3 Bayer Radiopharmaceutical Main Business and Markets Served

• 11.14.4 Bayer Radiopharmaceutical Product Portfolio

• 11.14.5 Recent Research and Development Strategies

• 11.15 Lantheus

• 11.15.1 Lantheus Company Details

• 11.15.2 Lantheus Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• 11.15.3 Lantheus Radiopharmaceutical Main Business and Markets Served

• 11.15.4 Lantheus Radiopharmaceutical Product Portfolio

• 11.15.5 Recent Research and Development Strategies

12 Global Radiopharmaceutical Market Outlook by Types and Applications to 2028

• 12.1 Global Radiopharmaceutical Consumption Forecast and Growth Rate by Type (2022-2028)

• 12.1.1 Global Actinium-225 Consumption Forecast and Growth Rate (2022-2028)

• 12.1.2 Global Lutetium-177 Consumption Forecast and Growth Rate (2022-2028)

• 12.1.3 Global Radium-223 Consumption Forecast and Growth Rate (2022-2028)

• 12.1.4 Global Holmium-166 Consumption Forecast and Growth Rate (2022-2028)

• 12.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

• 12.2 Global Radiopharmaceutical Consumption Forecast and Growth Rate by Application (2022-2028)

• 12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

• 12.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

13 Country-wise Radiopharmaceutical Market Analysis and Outlook to 2028

• 13.1 Global Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.2 North America Consumption Analysis

• 13.2.1 United States Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.2.2 Canada Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.2.3 Mexico Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.3 Europe Consumption Analysis

• 13.3.1 Germany Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.3.2 UK Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.3.3 Spain Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.3.4 Belgium Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.3.5 France Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.3.6 Italy Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.3.7 Denmark Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.3.8 Finland Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.3.9 Norway Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.3.10 Sweden Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.3.11 Poland Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.3.12 Russia Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.3.13 Turkey Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.4 APAC Consumption Analysis

• 13.4.1 China Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.4.2 Japan Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.4.3 India Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.4.4 South Korea Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.4.5 Pakistan Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.4.6 Bangladesh Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.4.7 Indonesia Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.4.8 Thailand Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.4.9 Singapore Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.4.10 Malaysia Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.4.11 Philippines Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.4.12 Vietnam Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.5 South America Consumption Analysis

• 13.5.1 Brazil Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.5.2 Colombia Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.5.3 Chile Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.5.4 Argentina Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.5.5 Venezuela Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.5.6 Peru Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.5.7 Puerto Rico Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.5.8 Ecuador Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.6 GCC Consumption Analysis

• 13.6.1 Bahrain Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.6.2 Kuwait Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.6.3 Oman Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.6.4 Qatar Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.6.5 Saudi Arabia Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.6.6 United Arab Emirates Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.7 Africa Consumption Analysis

• 13.7.1 Nigeria Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.7.2 South Africa Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.7.3 Egypt Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.7.4 Algeria Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.8 Oceania Consumption Analysis

• 13.8.1 Australia Radiopharmaceutical Consumption Forecast (2022-2028)

• 13.8.2 New Zealand Radiopharmaceutical Consumption Forecast (2022-2028)

14 Conclusions

The List of Tables and Figures

• Table Definition of Radiopharmaceutical

• Figure of Radiopharmaceutical Picture

• Table Global Radiopharmaceutical Import by Region (Top 10 Countries) (2017-2028)

• Table Global Radiopharmaceutical Export by Region (Top 10 Countries) (2017-2028)

• Figure Global Actinium-225 Consumption and Growth Rate (2017-2022)

• Figure Global Lutetium-177 Consumption and Growth Rate (2017-2022)

• Figure Global Radium-223 Consumption and Growth Rate (2017-2022)

• Figure Global Holmium-166 Consumption and Growth Rate (2017-2022)

• Figure Global Other Consumption and Growth Rate (2017-2022)

• Figure Global Hospital Consumption and Growth Rate (2017-2022)

• Figure Global Clinic Consumption and Growth Rate (2017-2022)

• Figure Global Radiopharmaceutical Consumption by Country (2017-2022)

• Table North America Radiopharmaceutical Consumption by Country (2017-2022)

• Figure United States Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Canada Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Mexico Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Table Europe Radiopharmaceutical Consumption by Country (2017-2022)

• Figure Germany Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure UK Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Spain Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Belgium Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure France Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Italy Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Denmark Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Finland Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Norway Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Sweden Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Poland Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Russia Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Turkey Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Table APAC Radiopharmaceutical Consumption by Country (2017-2022)

• Figure China Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Japan Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure India Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure South Korea Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Pakistan Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Bangladesh Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Indonesia Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Thailand Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Singapore Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Malaysia Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Philippines Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Vietnam Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Table South America Radiopharmaceutical Consumption by Country (2017-2022)

• Figure Brazil Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Colombia Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Chile Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Argentina Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Venezuela Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Peru Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Puerto Rico Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Ecuador Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Table GCC Radiopharmaceutical Consumption by Country (2017-2022)

• Figure Bahrain Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Kuwait Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Oman Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Qatar Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Saudi Arabia Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure United Arab Emirates Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Table Africa Radiopharmaceutical Consumption by Country (2017-2022)

• Figure Nigeria Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure South Africa Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Egypt Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure Algeria Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Table Oceania Radiopharmaceutical Consumption by Country (2017-2022)

• Figure Australia Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Figure New Zealand Radiopharmaceutical Consumption and Growth Rate (2017-2022)

• Table Triad Isotopes Company Details

• Table Triad Isotopes Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• Table Triad Isotopes Radiopharmaceutical Main Business and Markets Served

• Table Triad Isotopes Radiopharmaceutical Product Portfolio

• Table Navidea Company Details

• Table Navidea Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• Table Navidea Radiopharmaceutical Main Business and Markets Served

• Table Navidea Radiopharmaceutical Product Portfolio

• Table Eli Lilly Company Details

• Table Eli Lilly Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• Table Eli Lilly Radiopharmaceutical Main Business and Markets Served

• Table Eli Lilly Radiopharmaceutical Product Portfolio

• Table Bracco Imaging Company Details

• Table Bracco Imaging Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• Table Bracco Imaging Radiopharmaceutical Main Business and Markets Served

• Table Bracco Imaging Radiopharmaceutical Product Portfolio

• Table IBA Group Company Details

• Table IBA Group Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• Table IBA Group Radiopharmaceutical Main Business and Markets Served

• Table IBA Group Radiopharmaceutical Product Portfolio

• Table Jubilant Pharma Company Details

• Table Jubilant Pharma Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• Table Jubilant Pharma Radiopharmaceutical Main Business and Markets Served

• Table Jubilant Pharma Radiopharmaceutical Product Portfolio

• Table Nordion Company Details

• Table Nordion Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• Table Nordion Radiopharmaceutical Main Business and Markets Served

• Table Nordion Radiopharmaceutical Product Portfolio

• Table Mallinckrodt Company Details

• Table Mallinckrodt Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• Table Mallinckrodt Radiopharmaceutical Main Business and Markets Served

• Table Mallinckrodt Radiopharmaceutical Product Portfolio

• Table Advanced Accelerator Applications Company Details

• Table Advanced Accelerator Applications Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• Table Advanced Accelerator Applications Radiopharmaceutical Main Business and Markets Served

• Table Advanced Accelerator Applications Radiopharmaceutical Product Portfolio

• Table SIEMENS Company Details

• Table SIEMENS Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• Table SIEMENS Radiopharmaceutical Main Business and Markets Served

• Table SIEMENS Radiopharmaceutical Product Portfolio

• Table GE Healthcare Company Details

• Table GE Healthcare Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• Table GE Healthcare Radiopharmaceutical Main Business and Markets Served

• Table GE Healthcare Radiopharmaceutical Product Portfolio

• Table China Isotope & Radiation Company Details

• Table China Isotope & Radiation Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• Table China Isotope & Radiation Radiopharmaceutical Main Business and Markets Served

• Table China Isotope & Radiation Radiopharmaceutical Product Portfolio

• Table Dongcheng Company Details

• Table Dongcheng Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• Table Dongcheng Radiopharmaceutical Main Business and Markets Served

• Table Dongcheng Radiopharmaceutical Product Portfolio

• Table Bayer Company Details

• Table Bayer Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• Table Bayer Radiopharmaceutical Main Business and Markets Served

• Table Bayer Radiopharmaceutical Product Portfolio

• Table Lantheus Company Details

• Table Lantheus Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

• Table Lantheus Radiopharmaceutical Main Business and Markets Served

• Table Lantheus Radiopharmaceutical Product Portfolio

• Figure Global Actinium-225 Consumption Forecast and Growth Rate (2022-2028)

• Figure Global Lutetium-177 Consumption Forecast and Growth Rate (2022-2028)

• Figure Global Radium-223 Consumption Forecast and Growth Rate (2022-2028)

• Figure Global Holmium-166 Consumption Forecast and Growth Rate (2022-2028)

• Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

• Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

• Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

• Figure Global Radiopharmaceutical Consumption Forecast by Country (2022-2028)

• Table North America Radiopharmaceutical Consumption Forecast by Country (2022-2028)

• Figure United States Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Canada Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Mexico Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Table Europe Radiopharmaceutical Consumption Forecast by Country (2022-2028)

• Figure Germany Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure UK Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Spain Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Belgium Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure France Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Italy Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Denmark Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Finland Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Norway Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Sweden Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Poland Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Russia Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Turkey Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Table APAC Radiopharmaceutical Consumption Forecast by Country (2022-2028)

• Figure China Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Japan Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure India Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure South Korea Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Pakistan Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Bangladesh Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Indonesia Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Thailand Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Singapore Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Malaysia Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Philippines Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Vietnam Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Table South America Radiopharmaceutical Consumption Forecast by Country (2022-2028)

• Figure Brazil Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Colombia Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Chile Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Argentina Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Venezuela Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Peru Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Puerto Rico Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Ecuador Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Table GCC Radiopharmaceutical Consumption Forecast by Country (2022-2028)

• Figure Bahrain Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Kuwait Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Oman Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Qatar Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Saudi Arabia Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure United Arab Emirates Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Table Africa Radiopharmaceutical Consumption Forecast by Country (2022-2028)

• Figure Nigeria Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure South Africa Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Egypt Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure Algeria Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Table Oceania Radiopharmaceutical Consumption Forecast by Country (2022-2028)

• Figure Australia Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

• Figure New Zealand Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)